Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Michael A. Savin"'
Autor:
Luai S. Al Rabadi, Madeline M. Cook, Andy J. Kaempf, Megan M. Saraceni, Michael A. Savin, Zahi I. Mitri
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Docetaxel in combination with two HER2-directed therapies, trastuzumab and pertuzumab, is the current standard frontline therapy for patients with metastatic HER2-positive breast cancer. Ado-trastuzumab (T-DM1), an antibody-drug c
Externí odkaz:
https://doaj.org/article/2659c47324254f67bf9628d1989ae754
Publikováno v:
Journal of Geriatric Oncology. 10:311-316
OBJECTIVES: Older breast cancer survivors (BCS) consistently report more functional limitations than women without cancer, but whether or not these differences remain when using objective measures of physical functioning and the correlates of these m
Publikováno v:
Oncologist
Background The combination of everolimus (EVE) and exemestane (EXE) is approved for the treatment of patients with metastatic hormone receptor-positive breast cancer (mHRBC) who progress on nonsteroidal aromatase inhibitor (NSAI) therapy. However, no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99d04b6f013adb6ac9fd32b5767a9e7
https://europepmc.org/articles/PMC7873317/
https://europepmc.org/articles/PMC7873317/
Autor:
Mark A. Socinski, Amanda Barry, Blase N. Polite, Ravi Salgia, Peter G. Ellis, Ray D. Page, Kathy Lokay, Natalie R. Dickson, Corey Shamah, Casey Mason, Michael A. Savin
Publikováno v:
Journal of clinical pathways : the foundation of value-based care. 4(1)
Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non-small cell lung cancer (NSCLC), there is evidence that testing has not been widely
Autor:
Andrew Kennedy, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, Adeel Kaiser, Charles W. Nutting, Steven C. Rose, Eric A. Wang, Michael A. Savin
Publikováno v:
Journal of Gastrointestinal Oncology. 9:E13-E14
Autor:
Michael A. Savin, Brett Johnson, Gordon B. Mills, Joe W. Gray, Zahi Mitri, Swapnil Parmar, Kathleen Kemmer, Annette Kolodzie, Rochelle Williams-Belizaire, Jacqueline Vuky
Publikováno v:
Journal of Clinical Oncology. 37:TPS1111-TPS1111
TPS1111 Background: There is an urgent need to develop novel non chemotherapy treatments for metastatic triple negative breast cancer (mTNBC) patients who otherwise have a poor prognosis. Immune checkpoint blockade (ICB) and PARP inhibitors (PARPi) h
Autor:
Kazim H, Narsinh, Mark, Van Buskirk, Andrew S, Kennedy, Mohammed, Suhail, Naif, Alsaikhan, Carl K, Hoh, Kenneth, Thurston, Jeet, Minocha, David S, Ball, Steven J, Cohen, Michael, Cohn, Douglas M, Coldwell, Alain, Drooz, Eduardo, Ehrenwald, Samir, Kanani, Charles W, Nutting, Fred M, Moeslein, Michael A, Savin, Sabine, Schirm, Samuel G, Putnam, Navesh K, Sharma, Eric A, Wang, Steven C, Rose
Publikováno v:
Radiology. 282(1)
Purpose To determine if high lung shunt fraction (LSF) is an independent prognostic indicator of poor survival in patients who undergo yttrium 90 radioembolization for unresectable liver-dominant metastatic colorectal cancer. Materials and Methods Re
Publikováno v:
Chemotherapy. 58:387-398
Patients receiving cytotoxic chemotherapy are at risk for developing chemotherapy-induced neutropenia (CIN). Filgrastim, a recombinant granulocyte colony-stimulating factor (G-CSF) that stimulates the proliferation, differentiation and function of ne
Autor:
Andrew S, Kennedy, David S, Ball, Steven J, Cohen, Michael, Cohn, Douglas M, Coldwell, Alain, Drooz, Eduardo, Ehrenwald, Samir, Kanani, Charles W, Nutting, Fred M, Moeslein, Samuel G, Putnam, Steven C, Rose, Michael A, Savin, Sabine, Schirm, Navesh K, Sharma, Eric A, Wang
Publikováno v:
Journal of gastrointestinal oncology. 6(6)
To assess response and the impact of imaging artifacts following radioembolization with yttrium-90-labeled resin microspheres ((90)Y-RE) based on the findings from a central independent review of patients with liver-dominant metastatic colorectal can
Autor:
Michael H. Savin, Nicholas J. Speziale, Theodore J. Saclarides, William E. Altringer, José M. Dominguez, Shriram Jakate
Publikováno v:
Journal of Surgical Research. 61:293-299
The use of preoperative and intraoperative irradiation as surgical adjuncts in cancer management has led to concerns regarding post-operative wound healing. The optimum time to construct an intestinal anastomosis after irradiation has not been determ